Jerald B Taylor, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 435-623-3200 Fax: 435-623-3180 |
James M Besendorfer, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 435-623-3200 |
Grant J Rasmussen, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 435-623-3200 |
Mark C Oveson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 435-623-3200 Fax: 435-623-3265 |
James F Rosenbeck, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 435-623-3200 Fax: 435-623-3180 |
Emily Spencer Poff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 West 1500 North, Nephi, UT 84648 Phone: 435-623-3200 Fax: 435-623-3265 |
Jason Rock Standring, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 435-623-3200 Fax: 435-623-3180 |
Marc F Jones, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 48 W 1500 N, Nephi, UT 84648 Phone: 435-623-3200 Fax: 435-623-3180 |
News Archive
The American Dental Association (ADA) applauds Rep. Elijah Cummings (D-MD) for introducing legislation to help end the silent epidemic of untreated dental disease among the nation's disadvantaged children.
In a move that promises to expand the clinical testing of another promising malaria vaccine candidate, the US-based PATH Malaria Vaccine Initiative (MVI) and the Chinese company Shanghai Wanxing Bio-Pharmaceuticals today announced an agreement that supports the development of a pediatric malaria vaccine against Plasmodium (P.) falciparum, the most deadly strain of malaria.
I may say soda and you may say pop, but what if the hospital lab you go to today says BMP and the one you visit next week calls the same test SMA7? Your physician knows that these are the same tests, but the computer systems they use don't automatically know.
Dying in America is an expensive process, with about one in four Medicare dollars going to care for people in their last year of life. But for African Americans and Hispanics, the cost of dying is far higher than it is for whites.
A study, published in the November 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, showed the plasma test VeriStrat can predict response but not survival benefit from erlotinib. The study was conducted on a subset of patients enrolled in the NCIC Clinical Trials Group, BR.21 phase III trial of erlotinib versus placebo in previously treated advanced non-small cell lung cancer patients.
› Verified 6 days ago